Latest S-1 registration statements
NASDAQ
XCF Global, Inc. filed an S-1 registration statement for the potential resale of up to $50 million in Class A common stock by Helena Global Investment Opportunities I Ltd. through an equity line of credit, with proceeds intended for working capital and facility development amidst ongoing production issues and significant debt defaults.
NASDAQ
Miluna Acquisition Corp files S-1MEF to increase warrants in its public offering, enhancing unit structure.
Hyperliquid Strategies Inc. has entered into a $1.0 billion committed equity facility with Chardan Capital Markets LLC, enabling future stock sales to fund its HYPE token treasury strategy following a business combination.
NASDAQ
Bimergen Energy Corporation, a renewable energy project developer, filed an S-1/A for a public offering of common stock and pre-funded warrants, aiming to raise $10.6 million to advance its BESS and solar project pipeline.
NASDAQ
Evolution Global Acquisition Corp, a blank check company, filed an S-1/A for a $175 million initial public offering to target businesses in the critical minerals sector.
NASDAQ
Blueport Acquisition Ltd, a blank check company, filed an S-1/A for its initial public offering of 5,000,000 units at $10.00 each, aiming to raise $50,000,000 for a business combination.
NASDAQ
Alaunos Therapeutics, Inc. filed an S-1 for the resale of shares by Mast Hill Fund, L.P., outlining a potential $25 million equity financing and its strategic pivot to a preclinical oral obesity program.
OTC.Pink
ProPhase Labs files S-1 to register up to 226 million common shares for resale by selling stockholders, following a private placement and amidst significant business restructuring and Nasdaq compliance challenges.
Beeline Holdings, Inc. amended its common stock purchase agreement with C/M Capital Master Fund LP, boosting the commitment to $20 million and removing minimum price conditions.
NASDAQ
Algorhythm Holdings, Inc. is transitioning to focus solely on its AI-enabled logistics business, SemiCab, following the sale of its Singing Machine unit, while navigating significant financial challenges and recent capital raises.
NASDAQ
Graphjet Technology filed an S-1 registration statement for the resale of up to 7.8 million Class A Ordinary Shares by selling securityholders, revealing significant financial losses, ongoing Nasdaq compliance challenges, and a new $7 million loan.
NASDAQ
CISO
Ciso Global, INCCISO Global, Inc. filed an S-1/A registration statement for the resale of up to 39,062,500 shares of common stock by B. Riley Principal Capital, LLC, stemming from a $15 million Series B Preferred Stock purchase agreement.
Semnur Pharmaceuticals filed an S-1 registration statement, outlining its non-opioid pain product SP-102's development, recent business combination, and significant financial challenges including a going concern doubt.
OQB
Bunker Hill Mining Corp. files S-1 registration for resale of over 900 million common shares, detailing recent financings, debt restructuring, and mine development plans.
NASDAQ
Blink Charging Co. files an S-1 registration statement for the resale of 13.6 million common shares and warrants related to its Envoy Technologies acquisition, while disclosing substantial net losses and going concern doubt.
NASDAQ
Laser Photonics Corporation filed an S-1/A to register 3.87 million shares for resale by existing stockholders, including shares from recent private placements and warrant exercises, with no direct proceeds to the company from the resales.
Salarius Pharmaceuticals completes its merger with Decoy Therapeutics and initiates an $8 million public offering, significantly diluting existing shareholders while pivoting to a new peptide conjugate platform.
New Era Energy & Digital, Inc. files an S-1/A for a secondary offering of 5.2 million shares and a primary offering of 5.75 million shares underlying public warrants, while reporting significant net losses and liquidity concerns.
NASDAQ
SHF Holdings, Inc. files an S-1 registration statement for the resale of up to 52.28 million Class A Common Stock by selling stockholders, including shares from recent preferred stock and warrant issuances.
NASDAQ
Flux Power Holdings, Inc. files an S-1 registration statement for the resale of up to 3,644,289 shares of common stock by selling stockholders, following a $5.0 million private placement and ongoing efforts to address financial and listing compliance.
NASDAQ
UPXI
Upexi, INCUpexi, Inc. filed an S-1/A registration statement for the resale of up to 83,333,333 shares of common stock by A.G.P./Alliance Global Partners, while detailing its new Solana-focused digital asset treasury strategy.
NASDAQ
UPXI
Upexi, INCUpexi, Inc. has shifted its core strategy to a Solana-focused digital asset treasury, registering 48 million shares for resale by existing stockholders.
Aspira Womens Health Inc. filed an S-1/A to register 29,226,527 shares of common stock for resale by existing stockholders, stemming from recent financing activities.
NASDAQ
Grayscale Polkadot Trust ETF files an amended registration statement to offer shares providing investors with exposure to Polkadot (DOT) through a passive investment vehicle.
Grayscale Cardano Trust ETF files an amended registration statement for a spot Cardano (ADA) ETF, aiming to provide investors with exposure to ADA, including potential staking rewards, while highlighting significant digital asset market risks and regulatory uncertainties.
NASDAQ
Cellectar Biosciences, Inc. filed an S-1 registration statement for the resale of up to 2,096,188 shares of common stock by selling stockholders, following a recent warrant inducement transaction that generated $5.8 million in gross proceeds.
NASDAQ
Acurx Pharmaceuticals filed an S-1 registration statement for the resale of up to 585,000 common shares by Lincoln Park Capital Fund, LLC, enabling the company to potentially raise an additional $9.0 million.
NASDAQ
DEVS
Devvstream CORPDevvStream Corp. files S-1/A for the resale of 12.95 million common shares by a selling stockholder, highlighting its crypto treasury strategy and ongoing financial challenges.
Tvardi Therapeutics reported its lead candidate TTI-101 failed to meet goals in a Phase 2 IPF trial, while advancing its HCC program and acknowledging substantial future capital needs.
CLBZ
Collab Z INCCollab Z Inc. is pursuing an initial public offering of 1,250,000 shares at an assumed price of $4.00 per share to fund its AI-enhanced community-based property management platform and strategic growth initiatives.